What amount sold does Larx Fund 2, LP report in Form D filings?

The latest linked filings report $1.1M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Larx Fund 2, LP's most recent SEC filing?

Larx Fund 2, LP's most recent Form D filing was on 2022-04-04.

How many investors does Larx Fund 2, LP have?

The most recent Form D filing lists 2 investor(s).

Larx Fund 2, LP

CIK: 0001853637·Pooled Investment Fund·SAN JUAN, PR·Limited Partnership·Founded 2020

Reported Sold

$1,104,568

Total Filings

Identified Offerings

Last Filed

Apr 4, 2022

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pooled Investment Fund industry

SEC EDGAR

Offering filing timeline

Apr 4, 2022Form D/A — Amendment

Reported sold: $1,104,568 · Target: Indefinite

Rule 506(b)·2 investors·Section 3(c), Section 3(c)(1)

Changed: Reported amount sold

Apr 12, 2021Form D — New notice

Reported sold: $684,702 · Target: Indefinite

Rule 506(b)·2 investors·Section 3(c), Section 3(c)(1)

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

50%

Latest reported sold across 1 identified offering

$1,104,568

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Brandon Spruill

Related Person

Appears on 2 filings

Larx Capital, LLC

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 4, 2022	Amendment	Indefinite	$1,104,568	2
Apr 12, 2021	New	Indefinite	$684,702	2

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Convex Venture Fund, LP - Series 11

Pooled Investment Fund

Offering target: Indefinite

Filed Oct 30, 2026